Effect of phenobarbitone administration to pregnant rats on anxiety in offsprings

Indian Journal of Experimental Biology

Volumn 37, Issue 11, 1999, Pages 1070-1074

  Singh, K P ^a   Singh, M ^a   Jaiswal, A K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DRUG EFFECT; EXPLORATORY BEHAVIOR; MAZE TEST; NONHUMAN; PRENATAL DRUG EXPOSURE; PROGENY; RAT;

ANIMALS; ANXIETY; BRAIN; EXPLORATORY BEHAVIOR; FEMALE; MALE; MAZE LEARNING; PHENOBARBITAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS;

EID: 0032692472     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Myers R E & Myers S E, Am J Obste Gynecol, 133 (1979) 83.
2. Ransom B R & Elmore J G, in Advances in neurology, vol. 55, edited by D. Smith, D. Treiman & M Trimble (Raven Press, New York) 1991, 225.
3. O'connell E J, Feldt R H & Stickler G B, Pediatrics 36 (1965) 62.
4. Kleinberger N & Yanai J, Dev Brain Res, 22 (1985) 113.
5. Jacobson C D, Antolick L L, Scholey R & Uemura, Dev Brain Res, 44 (1988) 233.
6. Yanai J, Sze P Y, Iser C & Melamed E, Pharmacol Biochem Behav, 23 (1985) 215.
7. Bergman A, Rosselli-Austin L, Yedwab G & Yanai J, Acta Anat., 108 (1980) 370.
8. Pick C G & Yanai J, Int. J. Develop Neurosci, 2 (1984) 223.
9. Jaiswal A K & Bhattacharya S K, Indian J Exp Biol, 34 (1996) 118.
10. Middaugh L D, Simpson L W, Thomas T N & Zemp J W, Psychopharmacology, 74 (1981) 349.
11. Middaugh L D, Santos C A & Zemp J W, Pharmacol Biochem Behav, 3 (1975) 1137.
12. Leonard B E, Neuropharmacology, 20 (1981) 1237.
13. Spencer S S, Neurology, 51 (1998) 10.
14. Brönstein P M, J Comp Physiol Psychol, 80 (1972) 335.
15. Singh Y, Jaiswal A K, Singh M & Bhattacharya S K, Indian J Exp Biol, 34 (1996) 1095.
16. Singh Y, Jaiswal A K, Singh M & Bhattacharya S K, Indian J Exp Biol, 35 (1997) 1284.
17. Singh K P, Jaiswal A K, Singh M & Bhattacharya S K, Indian J Exp Biol, 36 (1998) 1102.
18. Pellow S & File S E, Pharmacol Biochem Behav, 24 (1986) 525.
19. Shepherd J K, Grewal S S, Fletcher A, Bill D J & Dourish C T, Psychopharmacology, 116 (1994) 56.
20. Yanai J, Roselli-Austin L & Tabakoff B, Exp Neurol, 64 (1979) 237.
21. Hannah R S, Roth S H & Spira A W, Exp Neurol, 100 (1988) 354.
22. Schain R J & Watanabe K, Exp Neurol, 47 (1975) 509.
23. Yanai J & Bergman A, Exp Neurol, 73 (1981) 199.
24. Fishman R H B, Gaathon A & Yanai J, Dev Brain Res, 5 (1982) 202.
25. Armitage S, J Comp Physiol Psychol, 45 (1952) 146.
26. Werboff J, Gottlieb J S, Havlena J & Word T J, Pediatrics, 27 (1961) 318.
27. File S E, in Selected models of anxiety, depression and psychosis, edited by Simpson P, Soubric P & Wildlocher D (Karger, Basel) 1988, 151.
28. Miller MW, J Comp Neurol, 287 (1989) 326.
29. Sun X Z, Inouye M, Hayasaka S, Takagishi Y & Yamamura H, Environ Medicine, 39 (1995) 113.
30. Berger B & Verney C, in Monoamine innervation of cerebral cortex, edited by Descarrics L, Reader T R & Jasper H H, Alan R Liss, New York, p. 347.
31. Holson R R, Webb P J, Crafton T F & Hansen D K, Teratology, 50 (1994) 125.
32. Zhang J, Wang L & Pitts D K, Neurotoxicol Teratol, 18 (1996) 49.
33. Thoenen H & Edgar D, Science, 229 (1985) 238.
34. Zemp J W & Middaugh L D, Addict Dis Int J, 2 (1975) 307.
35. Iser C & Yanai J, Proceedings of the European Teratology Society Meeting, 1984.
36. Wallace S J, in Neurobehavioural teratology, edited by Yanai J (Elsevier Science, BV) 1984, 133.